Insights into the Targeting Potential of Thymoquinone for Therapeutic Intervention Against Triple-negative Breast Cancer.

Abstract:

BACKGROUND:Thymoquinone (TQ) is a bioactive phytoconstituent obtained from Nigella sativa (black seeds). It has promising potential in cancer prevention. OBJECTIVE:Previous studies have shown that TQ can modulate signaling pathways responsible for cancer progression, thus enhancing the efficacy and improving the safety profile of clinically used anticancer drugs. METHOD:TQ acts on cell cycle and inhibits progression from G1 to S phase by targeting various proteins (cyclin D1, cyclin E, and p27). It also exhibits histone deacetylase (HDAC) inhibitory effects, targets p21 and Maspin, and induces pro-apoptotic gene, Bax and downregulates anti-apoptotic gene Bcl-2. Breast cancer (BC) is reported as one of the most common malignancies in women. RESULTS:Despite the research and advancement, it remains one of the most common causes of cancer related deaths among women. Recent advancements in molecular screening of BC led to the identification of clinically challenging condition of triple negative breast cancer (TNBC). TNBC is characterized by the absence of targetable receptors viz. estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2) expressions. It is also characterized by reduced or absence of phosphatase and tensin homolog (PTEN) expression, a tumor suppressor gene having diverse functions including regulation of apoptosis, cell cycle, and metastasis. CONCLUSION:Since TQ has been reported to up-regulate several growth factors such as vascular endothelial growth factor (VEGF), EGF and PTEN expression, the present review article discusses the targeting potential of TQ for therapeutic intervention against such types of breast cancer.

journal_name

Curr Drug Targets

journal_title

Current drug targets

authors

Barkat MA,Harshita,Ahmad J,Khan MA,Beg S,Ahmad FJ

doi

10.2174/1389450118666170612095959

subject

Has Abstract

pub_date

2018-01-01 00:00:00

pages

70-80

issue

1

eissn

1389-4501

issn

1873-5592

pii

CDT-EPUB-84018

journal_volume

19

pub_type

杂志文章,评审
  • Targeting JAK3 and BTK tyrosine kinases with rationally-designed inhibitors.

    abstract::Multifunctional rational drug design of protein tyrosine kinases inhibitors allows a potent drug to be utilized to treat more than one disease for greater patient benefits. Many protein tyrosine kinases (PTK), including Janus kinase 3 (JAK3) and Bruton's tyrosine kinase (BTK), have been identified as potential drug ta...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945006776054997

    authors: Vassilev AO,Tibbles HE,DuMez D,Venkatachalam TK,Uckun FM

    更新日期:2006-03-01 00:00:00

  • Intrathecal rituximab therapy in multiple sclerosis: review of evidence supporting the need for future trials.

    abstract::Rituximab has demonstrated a major effect in B-cell lymphoma and in a wide range of autoimmune disorders. Unfortunately, the blood-brain-barrier excludes the disorders restricted to the central nervous system (CNS) from the action of rituximab. The progressive phase of multiple sclerosis (MS) is a prototypical CNS aut...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450115666141029234644

    authors: Bonnan M,Ferrari S,Bertandeau E,Demasles S,Krim E,Miquel M,Barroso B

    更新日期:2014-01-01 00:00:00

  • Resveratrol as a chemopreventive agent: a promising molecule for fighting cancer.

    abstract::Resveratrol (3,4',5 tri-hydroxystilbene) is a phytoalexin produced in hudge amount in grapevine skin in response to infection by Bothrytis cinerea. This production of resveratrol blocks the proliferation of the pathogen, thereby acting as a natural antibiotic. Numerous studies have reported interesting properties of t...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945006776359331

    authors: Delmas D,Lançon A,Colin D,Jannin B,Latruffe N

    更新日期:2006-04-01 00:00:00

  • Is Galanin a Promising Therapeutic Resource for Neural and Nonneural Diseases?

    abstract:BACKGROUND:Galanin (GAL) constitutes a family of neuropeptides composed of four peptides: (i) galanin (GAL), (ii) galanin-message associated peptide (GAMP), (iii) galanin-like peptide (GALP), and (iv) alarin. GAL contains 29/30 amino acids, and its biological action occurs through the interactions with its various rece...

    journal_title:Current drug targets

    pub_type: 杂志文章

    doi:10.2174/1389450121666200225112055

    authors: Oliveira Volpe CM,Vaz T,Rocha-Silva F,Villar-Delfino PH,Nogueira-Machado JA

    更新日期:2020-01-01 00:00:00

  • Targeting the most upstream site of Wnt signaling pathway provides a strategic advantage for therapy in colorectal cancer.

    abstract::The Wnt signaling pathway has important functions in development, tissue homeostasis, and regeneration. Deregulation of canonical Wnt/beta-catenin signaling is frequently found in various human cancers, particularly in colorectal cancer, and non-canonical Wnt signaling pathways also have been implicated in neoplasia. ...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945008784911769

    authors: Qi J,Zhu YQ

    更新日期:2008-07-01 00:00:00

  • Recent Advances in Protein-Protein Docking.

    abstract::Protein-protein interactions (PPIs) play important roles in a variety of biological processes, and many PPIs have been regarded as biologically compelling targets for drug discovery. Extensive efforts have been made to develop feasible proteinprotein docking approaches to study PPIs in silico. Most of these approaches...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450117666160112112640

    authors: Zhang Q,Feng T,Xu L,Sun H,Pan P,Li Y,Li D,Hou T

    更新日期:2016-01-01 00:00:00

  • Decreasing the metastatic potential in cancers--targeting the heparan sulfate proteoglycans.

    abstract::The heterogeneity of proteoglycans (PG)s contributes to their functional diversity. Many functions depend on their ability to bind and modulate the activity of components of the extracellular matrix (ECM). The ability of PGs to interact with other molecules, such as growth factors, is largely determined by the fine st...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450054863662

    authors: Fjeldstad K,Kolset SO

    更新日期:2005-09-01 00:00:00

  • Chemopreventive and chemotherapeutic potential of curcumin in breast cancer.

    abstract::Breast cancer remains the leading cause of cancer death among females worldwide. It signifies a shift from the previous decade during which the most common cause of cancer death was cervical cancer. Current treatment modalities, including surgery, radiotherapy, and adjuvant chemotherapy or hormone therapy, have not be...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945012804545632

    authors: Sinha D,Biswas J,Sung B,Aggarwal BB,Bishayee A

    更新日期:2012-12-01 00:00:00

  • Aceruloplasminemia.

    abstract::Ceruloplasmin contains 95% of the copper in human serum and plays an important role in iron efflux from mammalian cells, including brain cells, due to the activity of ferroxidase, which oxidizes ferrous iron following its transfer to the cell surface via the iron transporter, ferroportin, and delivers ferric iron to e...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945012802002320

    authors: Kono S

    更新日期:2012-08-01 00:00:00

  • Modulation of the ceramide level, a novel therapeutic concept?

    abstract::The sphingomyelin (SM) pathway is an ubiquitous and evolutionarily conserved signaling system in which ceramide (CA), generated from SM by the action of various isoforms of sphingomyelinases (SMases) functions as an important second messenger. Recent evidence suggests that branching pathways of sphingolipid metabolism...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450003349272

    authors: Claus R,Russwurm S,Meisner M,Kinscherf R,Deigner HP

    更新日期:2000-09-01 00:00:00

  • Simultaneous interruption of signal transduction and cell cycle regulatory pathways: implications for new approaches to the treatment of childhood leukemias.

    abstract::The last decade has witnessed the introduction of a large number of novel, molecularly targeted agents into the therapeutic armamentarium against diverse forms of cancer, including leukemia. Such agents include signal transduction, cell cycle, histone deacetylase, Hsp90, proteasome, and Bcl-2 family member inhibitors,...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945007780830764

    authors: Grant S,Dent P

    更新日期:2007-06-01 00:00:00

  • Animal models of carcinogenesis in inflamed colorectum: potential use in chemoprevention study.

    abstract::Inflammation is a risk factor for cancer development in several tissues. In the colorectum, inflammatory bowel disease (ulcerative colitis and Crohn's disease) is a longstanding inflammatory disease with increased risk for colorectal cancer (CRC). Several molecular events involving in chronic inflammatory process cont...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945012804545452

    authors: Tanaka T

    更新日期:2012-12-01 00:00:00

  • Structure, pharmacology and therapeutic prospects of family C G-protein coupled receptors.

    abstract::Family C of G-protein coupled receptors (GPCRs) from humans is constituted by eight metabotropic glutamate (mGlu(1-8)) receptors, two heterodimeric gamma-aminobutyric acid(B) (GABA(B)) receptors, a calcium-sensing receptor (CaR), three taste (T1R) receptors, a promiscuous L-alpha-amino acid receptor (GPRC6A), and five...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945007779315614

    authors: Bräuner-Osborne H,Wellendorph P,Jensen AA

    更新日期:2007-01-01 00:00:00

  • Ion-Responsive Drug Delivery Systems.

    abstract:BACKGROUND:Some kinds of cations and anions are contained in body fluids such as blood, interstitial fluid, gastrointestinal juice, and tears at relatively high concentration. Ionresponsive drug delivery is available to design the unique dosage formulations which provide optimized drug therapy with effective, safe and ...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450117666160527142138

    authors: Yoshida T,Shakushiro K,Sako K

    更新日期:2018-02-08 00:00:00

  • Unique structural motif supports mannosylphospho dolichol synthase: an important angiogenesis regulator.

    abstract::Mannosylphospho dolichol synthase (DPMS) catalyzes the transfer reaction GDP-mannose + Dol-P <--> Dol-P-Man + GDP, a 'key step' in the assembly of lipid-linked oligosaccharide (LLO) and a pre-requisite for asparagine-linked (N-linked) protein glycosylation. DPMS is present from a protozoan parasite to human, and its s...

    journal_title:Current drug targets

    pub_type: 杂志文章

    doi:10.2174/138945008783954916

    authors: Baksi K,Tavárez-Pagán JJ,Martínez JA,Banerjee DK

    更新日期:2008-04-01 00:00:00

  • Beneficial effects of plant sources on the treatment of osteoporosis.

    abstract::Osteoporosis causes bone loss, and makes bone to susceptible to fracture. The main cause of osteoporosis is estrogen deficiency. Estrogen, calcitonin, calcium, vitamin D and antioxidants can be used to prevent osteoporosis. For the treatment of osteoporosis, the potential biological activities of traditional medicines...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/13894501113149990205

    authors: Süntar I,Akkol EK

    更新日期:2013-12-01 00:00:00

  • Adaptors in toll-like receptor signaling and their potential as therapeutic targets.

    abstract::To initiate the innate immune response, Toll-like receptors (TLRs) associate with cytoplasmic adaptor proteins through TIR (Toll/interleukin-1 receptor) domain interactions. The four principal signaling adaptor proteins include MyD88, MAL, TRIF and TRAM, and the fifth protein SARM, involved in negative regulation of T...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945012803530260

    authors: Ve T,Gay NJ,Mansell A,Kobe B,Kellie S

    更新日期:2012-10-01 00:00:00

  • A Review of Aberrant DNA Methylation and Epigenetic Agents Targeting DNA Methyltransferases in Endometriosis.

    abstract:BACKGROUND:Endometriosis (EMS) is a gynecological disease defined by the translocation and growth of endometrial tissue in other tissues or organs outside the uterus. Its clinical manifestations are dysmenorrhea, irregular menstruation, and even infertility. Although EMS is a benign disease, it has the characteristics ...

    journal_title:Current drug targets

    pub_type: 杂志文章

    doi:10.2174/1389450121666200228112344

    authors: Ding L,Yang L,Ren C,Zhang H,Lu J,Wang S,Wu Z,Yang Y

    更新日期:2020-01-01 00:00:00

  • Mechanism of Action: How Nano-Antimicrobials Act?

    abstract::Escalating resistance to almost every class of antibiotics is reducing the utility of currently available antimicrobial drugs. A part of this menace is attributed to poor pharmacokinetics and pharmacodynamics of the drug. Improvement in drug delivery is the most challenging task encountered by the pharmaceutical indus...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450116666151019101826

    authors: Jamil B,Bokhari H,Imran M

    更新日期:2017-01-01 00:00:00

  • Adipose tissue as a regulator of energy balance.

    abstract::Adipose tissue plays an active role in energy balance because it is not only a lipid storing and mobilizing tissue but consists of functionally specialized tissues able to produce heat (in brown adipose tissue) and to produce or release a vast number of so called adipokines or adipocytokines. These consist of polypept...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450043490523

    authors: Klaus S

    更新日期:2004-04-01 00:00:00

  • Sedation in PACU: indications, monitoring, complications.

    abstract::The aim of the present article is to review the indications, the monitoring and the complications of sedation in the post-anaesthesia care unit (PACU). In this setting, sedation is often an unwanted side effect of anaesthetic drugs that delay discharge, however it could be specifically indicated. Such indications incl...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945005774574542

    authors: De Gaudio AR,Rinaldi S

    更新日期:2005-11-01 00:00:00

  • Pharmacological therapies for pediatric and neonatal ALI/ARDS: an evidence-based review.

    abstract::Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are life-threating conditions still lacking a definite therapy and carrying a high mortality and morbidity, especially in children and infants. Albeit respiratory assistance and supportive therapies are crucial for ALI/ARDS, many drugs have been pr...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945012800675687

    authors: De Luca D,Piastra M,Tosi F,Pulitanò S,Mancino A,Genovese O,Pietrini D,Conti G

    更新日期:2012-06-01 00:00:00

  • Considering Circadian Pattern of Blood Pressure in the Treatment of Hypertension via Chronotherapy: A Conducive or Maladroit Approach.

    abstract::Medical chronobiology deals with the way body's rhythm influences a person's health and disease states. To match body rhythms, deliberate alteration of drug concentration is done to optimize therapeutic outcomes and minimize size effects and this approach is known as Chronotherapeutics. In general the concept of homeo...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450120666190527114529

    authors: Das R,Mehta DK

    更新日期:2019-01-01 00:00:00

  • Mucosal healing and anti TNFs in IBD.

    abstract::Mucosal healing has been incorporated in the assessment of treatment efficacy in ulcerative colitis, but in Crohn's disease this concept has only emerged after biological therapies have been evaluated in clinical trials. Systemic steroids don't induce mucosal healing in Crohn's disease, but purine analogues and anti T...

    journal_title:Current drug targets

    pub_type: 杂志文章

    doi:10.2174/138945010790309902

    authors: van Assche G,Vermeire S,Rutgeerts P

    更新日期:2010-02-01 00:00:00

  • Dysregulation of LncRNAs in Placenta and Pathogenesis of Preeclampsia.

    abstract:BACKGROUND:Preeclampsia, a gestational disease characterized by hypertension and proteinuria twenty weeks into pregnancy, is one of the leading causes of fetal and maternal mortality. Although multiple genetic and environmental factors are found to be related to the preeclampsia risk, the pathogenic pathways remain lar...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450118666170404160000

    authors: Song X,Luo X,Gao Q,Wang Y,Gao Q,Long W

    更新日期:2017-01-01 00:00:00

  • Saponins as tool for improved targeted tumor therapies.

    abstract::Saponins are plant glycosides that consist of a steroid, steroid alkaloid or triterpenoid aglycone and one or more sugar chains that are covalently linked by glycosidic binding to the aglycone. Glucose, galactose, glucuronic acid, xylose and rhamnose are commonly bound monosaccharides. Saponins are found in all organs...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945009787354584

    authors: Fuchs H,Bachran D,Panjideh H,Schellmann N,Weng A,Melzig MF,Sutherland M,Bachran C

    更新日期:2009-02-01 00:00:00

  • Hepatitis C virus proteins as targets for drug development: the role of bioinformatics and modelling.

    abstract::Hepatitis C virus (HCV), a member of the Flaviviridae family, has been recognised to be responsible for both parenterally transmitted and sporadic non-A and non-B hepatitis affecting 1-3% of the world population. HCV is a positive stranded RNA virus encoding a single polyprotein which contains at least ten unique stru...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450023347650

    authors: Lahm A,Yagnik A,Tramontano A,Koch U

    更新日期:2002-08-01 00:00:00

  • Can radiology replace endoscopy in IBD?

    abstract::Inflammatory bowel disease diagnostic and management algorithms continue to rapidly evolve. This is partly driven by advanced radiologic techniques that provide objective, non-invasive evaluations. The realms of information provided by radiology and endoscopy continue to be intertwined. This has led to the question of...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945012802429633

    authors: Bruining DH

    更新日期:2012-09-01 00:00:00

  • Downregulation of Membrane-bound Angiotensin Converting Enzyme 2 (ACE2) Receptor has a Pivotal Role in COVID-19 Immunopathology.

    abstract:BACKGROUND:The Coronavirus Disease 2019 (COVID-19) is becoming the major health issue in recent human history with thousands of deaths and millions of cases worldwide. Newer research and old experience with other corona-viruses highlighted a probable underlying mechanism of disturbance of the renin-angiotensin system (...

    journal_title:Current drug targets

    pub_type: 杂志文章

    doi:10.2174/1389450121666201020154033

    authors: Vieira C,Nery L,Martins L,Jabour L,Dias R,Simões E Silva AC

    更新日期:2020-10-20 00:00:00

  • Serotonin (5-HT) drugs: effects on appetite expression and use for the treatment of obesity.

    abstract::The pivotal role of 5-HT in the control of appetite was formally proposed nearly 30 years ago. In particular endogenous hypothalamic 5-HT has been implicated in the processes of within meal satiation and the end state of post meal satiety. Of the numerous 5-HT receptor subtypes currently identified, 5-HT(1B) and 5-HT(...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450053174550

    authors: Halford JC,Harrold JA,Lawton CL,Blundell JE

    更新日期:2005-03-01 00:00:00